IP
BLFS icon

Isthmus Partners’s BioLife Solutions BLFS Stock Holding History

Isthmus Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98M Buy
140,987
+3,035
+2% +$70.9K 0.38% 72
2026
Q1 		$2.63M Sell
137,952
-441
-0.3% -$9.75K 0.28% 98
2025
Q4 		$3.35M Buy
138,393
+622
+0.5% +$16.3K 0.37% 69
2025
Q3 		$3.52K Buy
137,771
+5,646
+4% +$134K ﹤0.01% 155
2025
Q2 		$2.85M Buy
132,125
+509
+0.4% +$11.5K 0.33% 81
2025
Q1 		$3.01M Sell
131,616
-168
-0.1% -$4.42K 0.38% 68
2024
Q4 		$3.42M Sell
131,784
-263
-0.2% -$6.54K 0.42% 61
2024
Q3 		$3.31M Sell
132,047
-33,200
-20% -$784K 0.39% 65
2024
Q2 		$3.54M Buy
165,247
+42,265
+34% +$820K 0.42% 71
2024
Q1 		$2.28M Buy
122,982
+45,900
+60% +$803K 0.26% 102
2023
Q4 		$1.25M Buy
77,082
+9,025
+13% +$115K 0.16% 108
2023
Q3 		$940K Buy
68,057
+6,171
+10% +$97.2K 0.14% 117
2023
Q2 		$1.37M Sell
61,886
-128
-0.2% -$2.7K 0.19% 103
2023
Q1 		$1.35M Buy
62,014
+1,469
+2% +$33K 0.19% 105
2022
Q4 		$1.1M Buy
60,545
+244
+0.4% +$5.04K 0.17% 108
2022
Q3 		$1.37M Buy
60,301
+3,178
+6% +$68K 0.24% 92
2022
Q2 		$789K Buy
57,123
+5,759
+11% +$84.5K 0.15% 107
2022
Q1 		$1.17M Buy
51,364
+23,608
+85% +$622K 0.19% 102
2021
Q4 		$1.03M Sell
27,756
-48
-0.2% -$2.06K 0.17% 106
2021
Q3 		$1.18M Sell
27,804
-21,353
-43% -$1.03M 0.21% 101
2021
Q2 		$2.19M Buy
49,157
+26
+0.1% +$916 0.39% 58
2021
Q1 		$1.77M Sell
49,131
-1,868
-4% -$73.9K 0.32% 70
2020
Q4 		$2.03M Sell
50,999
-9,145
-15% -$312K 0.41% 49
2020
Q3 		$1.74M Buy
60,144
+3,097
+5% +$66.9K 0.41% 47
2020
Q2 		$933K Buy
57,047
+6,632
+13% +$91.4K 0.23% 87
2020
Q1 		$479K Sell
50,415
-2,992
-6% -$41.1K 0.15% 100
2019
Q4 		$864K Buy
53,407
+36,800
+222% +$598K 0.2% 97
2019
Q3 		$276K Buy
+16,607
New +$312K 0.07% 130

Other funds holding BLFS

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Isthmus Partners's BLFS Position: Q2 2026 in Review

Isthmus Partners increased its BioLife Solutions (BLFS) stake by 2.2% in Q2 2026, buying an estimated $70.9K and bringing the position to 140,987 shares worth $3.98M. The position accounts for 0.38% of the portfolio, ranked #72.

Isthmus Partners first reported a position in BLFS in Q3 2019 and has held it in 28 quarters since. 52 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Isthmus Partners held 140,987 shares of BioLife Solutions worth $3.98M as of Q2 2026.
  • Isthmus Partners bought 3,035 BioLife Solutions shares in Q2 2026, an estimated $70.9K.
  • BioLife Solutions made up 0.38% of Isthmus Partners's portfolio in Q2 2026, its #72 holding.
  • Isthmus Partners first reported a position in BioLife Solutions in Q3 2019 and has held it in 28 quarters since.
  • 52 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.